Cerilli J, Fesperman D P
Surgery. 1976 Jul;80(1):92-7.
Seventy-one recipients of related donor renal allografts were tested for cellular immunity with the direct migration inhibition factor assay. Patients were divided into three groups on the basis of their responses in the assay. It was shown that all patients whose lymphocytes stimulated macrophage migration in vitro experienced more benign clinical courses than did those patients whose lymphocytes inhibited macrophage migration in vitro. The significance of a correlation between in vitro macrophage stimulation and clinical course is discussed.
对71例亲属供体肾移植受者进行了直接迁移抑制因子试验以检测细胞免疫。根据试验反应将患者分为三组。结果显示，淋巴细胞在体外刺激巨噬细胞迁移的所有患者，其临床病程比淋巴细胞在体外抑制巨噬细胞迁移的患者更为良性。讨论了体外巨噬细胞刺激与临床病程之间相关性的意义。
